Notably, patients with residual disease after radiation exhibited decreased levels of p65 and p50 subunits, along with an increased expression of NF-κB-p50 compared to the original tumor, suggesting altered NF-κB signaling in radiation-resistant tumors [29]. The gene discussed is NFKB1; the disease is neoplasm.